Navigation Links
For Multiple Myeloma Treatment, More Surveyed European Clinicians Consider the Combination of Immunomodulatory Agents and Proteasome Inhibitors Promising With Respect to Efficacy Than Any Other Drug Regimen Combinations
Date:9/23/2010

apsed from or refractory to Velcade to be candidates for carfilzomib in combination with Revlimid.

The report also finds that surveyed payers in both Germany and Spain are questioning how long automatic reimbursement of drugs that have been approved by the European Medicines Agency can last. While several countries have imposed mandatory price cuts on pharmaceuticals, or will do so imminently, the uncertain future of automatic reimbursement policies may have an even more significant market impact than mandatory price cuts.

"Interviewed payers have warned that the days of automatic reimbursement of high-cost targeted cancer therapies may be numbered, particularly when multiple new drugs become available for an indication like myeloma," Dr. Merron said.

The report is based on a survey of 251 hematologist-oncologists from Germany (52), France (50), Italy (49), Spain (50) and the United Kingdom (50) and interviews with 15 European payers from Germany (3), France (3), Italy (3), Spain (3) and the United Kingdom (3).

About Decision ResourcesDecision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Deci
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer
2. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
3. Fertility Drugs Contribute Heavily to Multiple Births
4. Clinical Benefits of Electronic Brachytherapy From Xoft Substantiated for the Treatment of Multiple Cancers
5. Volcano Announces Plans to Introduce Multiple New Products at EuroPCR 2010
6. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
7. Fortis Hospitals Puts 27 Year Old Nigerian Back on her Feet After Multiple Joint Replacement Surgery
8. SRI International Researchers Present Promising New Therapeutic for the Treatment of Multiple Myeloma
9. Multiple Chemical Sensitivities Are Real
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has announced the ... Global Forecasts to 2019" report to their offering. ... estimated to grow expected to reach $9.37 billion by ... 2019. Factors such as growing ... increasing privatization in the healthcare sector, and rising adoption ...
(Date:7/28/2015)... 2015 A German Diabetes Center clinical study ... probiotic enriches human gut microbiota and modifies gut ... study involved daily administration of Nutraceutix,s L. reuteri ... patented BIO- tract ® delivery technology that ... their way to the intestinal tract. The ...
(Date:7/28/2015)... ATLANTA , July 28, 2015  SeraCare ... vitro diagnostics manufacturers, announced today at the American ... has signed a licensing agreement with the University ... of Trisomy 21 (T21), Trisomy 18 (T18) and ... a component for creating "patient-like" reference materials for ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3
... Satellite Symposium -, SOUTH SAN FRANCISCO, Calif., ... ), a biopharmaceutical company focused,on oncology, today announced ... prostate cancer patients from its Phase 1 study ... 2008 Genitourinary (GU) Cancers,Symposium, a meeting of the ...
... a landmark study,electronically published today in the American ... test for detecting TB infection,QuantiFERON(R)-TB Gold (QFT(TM)), has ... the conventional tuberculin skin test (TST) at predicting,which ... TB,disease. This study has important implications for the ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 2Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 3Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 4Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 5Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control 2Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control 3Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control 4
(Date:7/29/2015)... ... July 29, 2015 , ... Several years ago, in order ... with autism, Little City took a proactive stance and began planning the Children’s Village ... grant provides valuable support to building the third home. , “We are very pleased ...
(Date:7/29/2015)... ... 29, 2015 , ... Attorneys representing American families in national talcum powder lawsuits ... now features a page dedicated to news related to pending talcum powder lawsuits, as ... Powder Lawsuit News page was launched with eight initial articles. , “We decided ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Since the late 1970s, Dr. Cottrell has been making predictions about the economy, ... Earth, documents many of these prognostications. He warns that extreme weather conditions and ...
(Date:7/29/2015)... , ... July 29, 2015 , ... " mybody ” ... look at small, medium and large businesses making an impact in their industry. Andrew ... with viewers how these advanced probiotic skincare products are designed to strengthen the skin’s ...
(Date:7/29/2015)... Charlotte, North Carolina (PRWEB) , ... July 29, ... ... that MetLife, Inc ., a global provider of life insurance, annuities, employee ... Adventure Team Challenge North Carolina inclusive sporting event taking place in Charlotte, ...
Breaking Medicine News(10 mins):Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3
... May 7 Select Medical Corporation,will release the financial ... Thursday, May 15, 2008., The Company will host ... May 21, 2008, at 11:00am EDT. The domestic dial ... in number is,1-210-839-8503. The passcode for the call is ...
... rewiring needed for neural development, mouse study shows , , ... of weight-loss drugs that suppresses appetite by blocking cannabinoid ... in children, U.S. scientists report. , In research with ... the adaptive rewiring of the brain necessary for neural ...
... increase adults risk for having dementia, according to researchers ... Their analysis of published obesity and dementia prospective ... consistent relationship between the two diseases. The results are ... Obesity in the May, 2008 issue of Obesity Reviews. ...
... Hemoglobin-Based Oxygen Carriers Indicates Support for Continued ... Investigational Use Where Blood Is Not an Option, ... ) announced today that the Company,s strategy to pursue,indications ... when blood is not an option was reinforced by ...
... need for Americans ... be screened for glucose levels, WASHINGTON, May 7 The ... improve the lives,of people with diabetes, joined together with other advocacy ... 2015, 45% of,Americans or approximately 59 million adults, who are at-risk ...
... A UQ researcher has created a new way to measure ... adults. , The researcher, PhD student Philip Terrill, has ... indicate different sleep states such as active or quiet sleep. ... child,s chest, recorded breathing rates which were then analysed using ...
Cached Medicine News:Health News:Obesity linked to increased risk for dementia 2Health News:Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop 2Health News:Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop 3Health News:Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop 4Health News:Leading Advocacy Groups Set National Diabetes Goal 2Health News:Leading Advocacy Groups Set National Diabetes Goal 3Health News:Leading Advocacy Groups Set National Diabetes Goal 4Health News:Leading Advocacy Groups Set National Diabetes Goal 5
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
... is light weight state-of-the-art precision ... design is adaptable to a ... Classic Stepper features a secure ... clockwise and counter-clockwise rotation with ...
Simply squeeze the trigger for free motion in any direction, guide the probe to the desired position, and release the trigger to hold it in place....
Floor stand stabilizer system...
Medicine Products: